Acomplia - Frequently asked questions
What is acomplia?
Acomplia is a slimming drug that is designed to help those who are very overweight to slim down to a safer weight. Obesity is a big problem in many countries and those that are obese can experience many serious health issues resulting from their obesity. Acomplia is designed to help people in this situation to reach a safer weight more quickly so that they can reduce the chances of contracting related illness such as heart problems and diabetes.
How does this medication work?
The way in which Acomplia works in order to help people to lose weight is by suppression of the appetite. When you take Acomplia you will feel less hungry and will want to eat less often. This naturally reduces the amount of calories and fat that you consume each day, which leads to natural weight loss. It is, like most other slimming medications, designed to be taken alongside a healthy eating plan and regular exercise. It is also said to increase the body's metabolic rate, which means that you will be able to burn fat and calories more quickly and will have more energy.
What are the side effects of Acomplia?
There are a number of side effects that are linked to Acomplia and it is important for anyone that is considering this medication to look into the side effects before making a decision. Some of the side effects are pretty common ones with a variety of medications, such as nausea, headaches, dizzy spells and vomiting. However, there can also be more serious psychological side effects, which is why this medication is not recommended for those that suffer from any mental health problems.
How do I know whether it will suit me?
It can be difficult for a person to decide whether Acomplia will suit them based on knowing about the side effects alone. The suitability of this drug will depend on a number of things, such as your medical history, any medications that you are taking, etc. You should therefore speak to your physician if you have any doubts as to the suitability of this medication.